9/10/2013 8:52:12 AM
Just a few months after announcing several new partnerships and landing venture capital dollars, Nuclea Biotechnologies Inc. has snapped up Oncogene Science, an Cambridge, Mass.-based subsidiary of Wilex AG in Germany. The Pittsfield, Mass.-based company, with offices in Worcester, acquired all of the shares of Oncogene (Wilex Inc.) and will assume the assets of the company and take over repayment of a $2.5 million loan between the company and Wilex AG. Nuclea paid $5 million for the 11-person company and all of the employees will transition over to Nuclea, Spokesperson Greg D'Agostino said.
Help employers find you! Check out all the jobs and post your resume.
comments powered by